Publications

Private equity investment in life sciences sector

Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.

par plusieurs auteurs

4 de 6 Publications

Licensing out: Try not to get benched

par Colin McCall et Justyna Ostrowska

UK increases scrutiny of tech and life sciences deals

Mergers and acquisitions in the tech and life sciences sectors may be subject to closer scrutiny by the UK competition authority and by the UK government in future.

par Paolo Palmigiano

6 de 6 Publications

Arbitration for life sciences companies

par plusieurs auteurs

Legal advice privilege: where are we now?

par Georgina Jones

Brexit and MDR readiness for overseas medical devices manufacturers: where should you locate your sales operations in Europe?

par Alison Dennis

Territorial licensing: "start at the end before you begin"

par Colin McCall et Justyna Ostrowska

A missed chance

par Dr. Anja Lunze, LL.M. et Verena Bertram

Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?

An exploration of patent pools, R&D and current initiatives.

par Dr. Anja Lunze, LL.M. et Dr. Jan Phillip Rektorschek

2 de 6 Publications

COVID-19 and life sciences M&A

par plusieurs auteurs

Special approvals of the Federal Institute for Drugs and Medical Devices for the distribution of medical devices and FFP breathing masks without an expiration valve

par Dr. Daniel Tietjen